Valuation: Kissei Pharmaceutical Co., Ltd.

Market Cap 166B 1.05B 926M 874M 797M 1.49B 101B 1.5B 10.46B 4.05B 51.66B 3.96B 3.88B P/E 2027 *
13.4x
P/E 2028 * 20x
Enterprise Value 102B 648M 568M 537M 489M 916M 62.07B 922M 6.42B 2.49B 31.71B 2.43B 2.38B EV / Sales 2027 *
1.12x
EV / Sales 2028 * 1.08x
Free-Float
67.39%
Yield 2027 *
4.24%
Yield 2028 * 3.43%
1 day+0.25%
Current month-2.20%
1 month-2.55%
3 months-1.72%
6 months-14.79%
Current year-13.87%
1 week 3,985
Extreme 3985
4,055
1 month 3,935
Extreme 3935
4,135
Current year 3,500
Extreme 3500
5,040
1 year 3,500
Extreme 3500
5,040
3 years 2,907
Extreme 2907
5,040
5 years 2,132
Extreme 2132
5,040
10 years 2,002
Extreme 2002
5,040
Manager TitleAgeSince
Chief Executive Officer 76 2014-05-31
Director of Finance/CFO 64 2012-05-31
President 65 2022-06-22
Director TitleAgeSince
Chairman 76 2014-05-31
Director/Board Member 74 2006-05-31
Director/Board Member 71 2008-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%0.00%-9.90%+17.45% 1.05B
+0.54%+1.30%+89.38%+41.17% 367B
+0.78%+3.97%+26.64%-14.56% 66.89B
-1.15%+1.29%+54.44%+196.07% 12.93B
+0.24%+0.49%-1.78%-14.49% 7.54B
-1.30%-2.32%-25.22%-10.07% 4.38B
-1.33%-2.37%-35.40%+4.72% 4.07B
-4.23%+2.14%-28.86%-12.33% 3.02B
-1.46%+1.57%-9.29%+46.05% 2.48B
-2.18%-0.66%-20.69%-32.24% 1.91B
Average -0.98%-0.02%+3.93%+22.18% 47.13B
Weighted average by Cap. +0.44%+0.18%+73.97%+35.16%

Financials

2027 *2028 *
Net sales 90.82B 577M 506M 478M 436M 816M 55.32B 822M 5.72B 2.22B 28.26B 2.17B 2.12B 91.93B 584M 513M 484M 441M 826M 55.99B 832M 5.79B 2.24B 28.6B 2.19B 2.15B
Net income 12.49B 79.35M 69.63M 65.76M 59.93M 112M 7.6B 113M 787M 305M 3.89B 298M 291M 7.85B 49.86M 43.75M 41.32M 37.66M 70.49M 4.78B 70.99M 494M 192M 2.44B 187M 183M
Net Debt -64.1B -407M -357M -338M -308M -576M -39.04B -580M -4.04B -1.56B -19.94B -1.53B -1.5B -66.3B -421M -370M -349M -318M -596M -40.38B -600M -4.18B -1.62B -20.63B -1.58B -1.55B
Logo Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.
Employees
1,786
Date Price Change Volume
26-09-25 JP¥4,005.00 +0.25% 54,900
26-09-24 JP¥3,995.00 -0.25% 60,000
26-09-18 JP¥4,005.00 -0.37% 118,400
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
4,005.00JPY
Average target price
4,566.67JPY
Spread / Average Target
+14.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4547 Stock